In this study we investigated the prognostic value of estrogen receptor α (ERα), ERβ and progesterone receptor (PR) expression in 58 untreated advanced serous ovarian cancer patients. The study also included 12 macroscopically and histopathologically normal ovaries.
De Stefano, I., Zannoni, G. F., Prisco, M., Fagotti, A., Tortorella, L., Vizzielli, G., Mencaglia, L., Scambia, G., Gallo, D., Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer, <<GYNECOLOGIC ONCOLOGY>>, 2011; 122 (3): 573-579. [doi:10.1016/j.ygyno.2011.05.025] [http://hdl.handle.net/10807/27827]
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer
De Stefano, Ilaria;Zannoni, Gian Franco;Fagotti, Anna;Vizzielli, Giuseppe;Scambia, Giovanni;
2011
Abstract
In this study we investigated the prognostic value of estrogen receptor α (ERα), ERβ and progesterone receptor (PR) expression in 58 untreated advanced serous ovarian cancer patients. The study also included 12 macroscopically and histopathologically normal ovaries.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.